Article Details
Retrieved on: 2019-04-01 19:27:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>... LYNPARZA IN BRCA-MUTATED, HER2-NEGATIVE METASTATIC; 22/03/2018 – <b>Third Rock Ventures</b> Launches Rheos Medicines with $60 Million ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here